The question some investors ask is whether the Ashcroft Capital Lawsuit would draw regulatory measures. Some of the claims in the case, including misleading projections and inadequate disclosures of risks, create potential concerns regarding partners in the securities law, including Rule 10b-5, which prohibits fraudulent statements in securities offerings. The discovery of more generalized instances of non-disclosure or misrepresentation may be followed by parallel investigations by the Securities and Exchange Commission (SEC) or state authorities, but no regulatory action is officially presented.